Triple/Dual Agonist Stack
Most metabolic research compounds investigate a single signaling pathway.
This investigational blend brings together Retatrutide (5 mg)—studied for activity at the GLP-1, GIP, and glucagon receptors—with Cagrilintide (5 mg), an amylin analog studied for its role in satiety signaling and gastric emptying.
Together, they enable investigation across four complementary biological pathways involved in appetite regulation, energy expenditure, glucose metabolism, and meal termination.
Four Complementary Research Pathways
GLP-1 Receptor
Studied for its role in appetite regulation, insulin secretion, gastric emptying, and glucose homeostasis.
GIP Receptor
Investigated for effects on insulin signaling, adipose tissue biology, and metabolic regulation.
Glucagon Receptor
Studied for its role in hepatic metabolism, fat utilization, and energy expenditure.
Amylin Receptor
Investigated for its influence on satiety signaling, meal size, meal frequency, gastric emptying, and post-prandial glucagon regulation through pathways that are distinct from GLP-1 signaling.
Why Researchers Are Watching This Combination
Retatrutide expands metabolic research beyond traditional GLP-1 agonism by adding GIP and glucagon receptor activity. Cagrilintide contributes a complementary amylin-based pathway involved in satiety and meal termination.
Rather than focusing on a single biological mechanism, this blend allows researchers to investigate how multiple signaling systems may interact within the same experimental framework.
Triple/Dual Agonist Stack
Most metabolic research compounds investigate a single signaling pathway.
This investigational blend brings together Retatrutide (5 mg)—studied for activity at the GLP-1, GIP, and glucagon receptors—with Cagrilintide (5 mg), an amylin analog studied for its role in satiety signaling and gastric emptying.
Together, they enable investigation across four complementary biological pathways involved in appetite regulation, energy expenditure, glucose metabolism, and meal termination.
Four Complementary Research Pathways
GLP-1 Receptor
Studied for its role in appetite regulation, insulin secretion, gastric emptying, and glucose homeostasis.
GIP Receptor
Investigated for effects on insulin signaling, adipose tissue biology, and metabolic regulation.
Glucagon Receptor
Studied for its role in hepatic metabolism, fat utilization, and energy expenditure.
Amylin Receptor
Investigated for its influence on satiety signaling, meal size, meal frequency, gastric emptying, and post-prandial glucagon regulation through pathways that are distinct from GLP-1 signaling.
Why Researchers Are Watching This Combination
Retatrutide expands metabolic research beyond traditional GLP-1 agonism by adding GIP and glucagon receptor activity. Cagrilintide contributes a complementary amylin-based pathway involved in satiety and meal termination.
Rather than focusing on a single biological mechanism, this blend allows researchers to investigate how multiple signaling systems may interact within the same experimental framework.
